{"id":131482,"date":"2026-06-25T17:25:05","date_gmt":"2026-06-25T11:55:05","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=131482"},"modified":"2026-06-25T17:25:07","modified_gmt":"2026-06-25T11:55:07","slug":"rubicon-research-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/","title":{"rendered":"Rubicon Research Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>The Rubicon Research share price target 2026 is Rs 1,700, implying approximately 20 percent upside from the current market price of Rs 1,408 (NSE: RUBICON). With Q4 FY26 results released in 2026 and Pharmaceutical CDMO and Formulations tailwinds in focus, the Rs 1,700 price objective is supported by the FY27 earnings recovery thesis.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/stocks\/rubicon\/rubicon-research-limited-share-price-today\">Rubicon Research<\/a> (NSE: RUBICON) is a Pharmaceutical CDMO and Formulations company trading at Rs 1,408 with a market capitalisation of Rs 23,037 crore. Analysts have set the <strong>Rubicon Research share price target<\/strong> at Rs 1,700 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Rubicon_Research_Share_Price_Target_2026_Key_Takeaways\" title=\"Rubicon Research Share Price Target 2026: Key Takeaways\">Rubicon Research Share Price Target 2026: Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Rubicon_Research_Company_Overview\" title=\"Rubicon Research Company Overview\">Rubicon Research Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Why_Is_the_Rubicon_Research_Share_Price_Target_Set_at_Rs_1700_for_2026\" title=\"Why Is the Rubicon Research Share Price Target Set at Rs 1,700 for 2026\">Why Is the Rubicon Research Share Price Target Set at Rs 1,700 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#FY27_Earnings_Recovery_and_Revenue_Acceleration\" title=\"FY27 Earnings Recovery and Revenue Acceleration\">FY27 Earnings Recovery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Pharmaceutical_CDMO_and_Formulations\" title=\"Structural Sector Tailwinds in Pharmaceutical CDMO and Formulations\">Structural Sector Tailwinds in Pharmaceutical CDMO and Formulations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Union_Budget_2026-27_Capex_Push_and_Policy_Support\" title=\"Union Budget 2026-27 Capex Push and Policy Support\">Union Budget 2026-27 Capex Push and Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#FII_Flow_Normalisation_After_the_2026_Tariff_Shock\" title=\"FII Flow Normalisation After the 2026 Tariff Shock\">FII Flow Normalisation After the 2026 Tariff Shock<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Rubicon_Research_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Rubicon Research Share Price Targets: Short Term, 12 Month, and Long Term\">Rubicon Research Share Price Targets: Short Term, 12 Month, and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Short_Term_Rubicon_Research_Share_Price_Target\" title=\"Short Term Rubicon Research Share Price Target\">Short Term Rubicon Research Share Price Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#12-Month_Rubicon_Research_Share_Price_Target_2026\" title=\"12-Month Rubicon Research Share Price Target 2026\">12-Month Rubicon Research Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Long_Term_Rubicon_Research_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Rubicon Research Share Price Target: FY27 to FY28\">Long Term Rubicon Research Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Bull_Case_and_Bear_Case_Scenarios_for_Rubicon_Research_in_2026\" title=\"Bull Case and Bear Case Scenarios for Rubicon Research in 2026\">Bull Case and Bear Case Scenarios for Rubicon Research in 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Bull_Case_Rubicon_Research_Share_Price_Target_Rs_2050\" title=\"Bull Case Rubicon Research Share Price Target: Rs 2,050\">Bull Case Rubicon Research Share Price Target: Rs 2,050<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Bear_Case_Rubicon_Research_Share_Price_Target_Rs_1150\" title=\"Bear Case Rubicon Research Share Price Target: Rs 1,150\">Bear Case Rubicon Research Share Price Target: Rs 1,150<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Key_Risks_That_Could_Derail_the_Rubicon_Research_2026_Price_Objective\" title=\"Key Risks That Could Derail the Rubicon Research 2026 Price Objective\">Key Risks That Could Derail the Rubicon Research 2026 Price Objective<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Global_Macro_and_US_Tariff_Headwinds\" title=\"Global Macro and US Tariff Headwinds\">Global Macro and US Tariff Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#FY27_Earnings_Miss_and_Guidance_Risk\" title=\"FY27 Earnings Miss and Guidance Risk\">FY27 Earnings Miss and Guidance Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Competitive_Intensity_Among_Pharmaceutical_CDMO_and_Formulations_Peers\" title=\"Competitive Intensity Among Pharmaceutical CDMO and Formulations Peers\">Competitive Intensity Among Pharmaceutical CDMO and Formulations Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Liquidity_Risk_and_FII_Selling_Pressure\" title=\"Liquidity Risk and FII Selling Pressure\">Liquidity Risk and FII Selling Pressure<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#How_to_Invest_in_Rubicon_Research\" title=\"How to Invest in Rubicon Research\">How to Invest in Rubicon Research<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#FAQs_on_Rubicon_Research_Share_Price_Target_2026\" title=\"FAQs on Rubicon Research Share Price Target 2026\">FAQs on Rubicon Research Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#What_is_the_Rubicon_Research_share_price_target_for_2026\" title=\"What is the Rubicon Research share price target for 2026?\">What is the Rubicon Research share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#What_was_the_Rubicon_Research_share_price_target_for_2025\" title=\"What was the Rubicon Research share price target for 2025?\">What was the Rubicon Research share price target for 2025?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#Is_Rubicon_Research_a_good_investment_at_Rs_1408\" title=\"Is Rubicon Research a good investment at Rs 1,408?\">Is Rubicon Research a good investment at Rs 1,408?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#What_are_the_key_risks_to_the_Rubicon_Research_share_price_target_2026\" title=\"What are the key risks to the Rubicon Research share price target 2026?\">What are the key risks to the Rubicon Research share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_Rubicon_Research\" title=\"What is the 52 week high and low of Rubicon Research?\">What is the 52 week high and low of Rubicon Research?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#What_are_the_main_growth_catalysts_for_Rubicon_Research_in_2026\" title=\"What are the main growth catalysts for Rubicon Research in 2026?\">What are the main growth catalysts for Rubicon Research in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#How_does_Rubicon_Research_compare_to_its_peers\" title=\"How does Rubicon Research compare to its peers?\">How does Rubicon Research compare to its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-target-2026\/#What_is_the_Rubicon_Research_share_price_target_for_2027\" title=\"What is the Rubicon Research share price target for 2027?\">What is the Rubicon Research share price target for 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Rubicon_Research_Share_Price_Target_2026_Key_Takeaways\"><\/span><strong>Rubicon Research Share Price Target 2026: Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Rubicon Research share price target 2026:<\/strong> Rs 1,700 (20% upside from CMP Rs 1,408)<\/li>\n<li><strong>Bull case:<\/strong> Rs 2,050 | <strong>Bear case:<\/strong> Rs 1,150<\/li>\n<li><strong>Ticker:<\/strong> RUBICON | <strong>Sector:<\/strong> Pharmaceutical CDMO and Formulations | <strong>MCap:<\/strong> Rs 23,037 crore<\/li>\n<li><strong>52W range:<\/strong> Rs 570.75 to Rs 1,469 | <strong>PE:<\/strong> 25x<\/li>\n<li><strong>Key catalyst:<\/strong> Q4 FY26 results and FY27 earnings confirmation in 2026<\/li>\n<li><strong>Key risk:<\/strong> FY27 earnings miss or FII outflows from Indian equities<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Rubicon_Research_Company_Overview\"><\/span><strong>Rubicon Research Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Rubicon Research (NSE: RUBICON) is a Mumbai-based pharmaceutical CDMO specialising in controlled-release oral solid dosage forms, orally disintegrating tablets, and modified release drug delivery for the US, Europe, and Japan markets. At CMP Rs 1,408 against a 52 week range of Rs 570.75 to Rs 1,469, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 23,037 crore with trailing PE of 25x. Compared to peers in CDMO like Suven Pharma and Piramal Pharma, Rubicon Research is positioned as a potential re-rating candidate toward the Rs 1,700 price objective on FY27 earnings delivery.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>RUBICON<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceutical CDMO and Formulations<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 1,408<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 1,469<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 570.75<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 23,037 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing PE<\/td>\n<td>25x<\/td>\n<\/tr>\n<tr>\n<td>12-Month Analyst Target<\/td>\n<td>Rs 1,700<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 2,050<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 1,150<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Rubicon_Research_Share_Price_Target_Set_at_Rs_1700_for_2026\"><\/span><strong>Why Is the Rubicon Research Share Price Target Set at Rs 1,700 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Recovery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Recovery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Rubicon Research share price target<\/strong> of Rs 1,700 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for re-rating from CMP Rs 1,408.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Pharmaceutical_CDMO_and_Formulations\"><\/span><strong>Structural Sector Tailwinds in Pharmaceutical CDMO and Formulations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Pharmaceutical CDMO and Formulations sector is expanding on the back of India&#8217;s domestic demand growth, PLI scheme support, and rising corporate investment. Rubicon Research&#8217;s position among peers in CDMO like Suven Pharma and Piramal Pharma creates a structural growth runway, with sustained outperformance being one of the key conditions for the Rs 2,050 bull case to materialise.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Rubicon Research&#8217;s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 1,700 analyst consensus.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Capex_Push_and_Policy_Support\"><\/span><strong>Union Budget 2026-27 Capex Push and Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable backdrop for Rubicon Research&#8217;s Pharmaceutical CDMO and Formulations operations, improving the probability of achieving the Rs 1,700 price objective through FY27 earnings delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Flow_Normalisation_After_the_2026_Tariff_Shock\"><\/span><strong>FII Flow Normalisation After the 2026 Tariff Shock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 25x PE, Rubicon Research is positioned as a beneficiary of institutional reallocation toward the Rs 2,050 bull case over the medium term.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Rubicon_Research_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Rubicon Research Share Price Targets: Short Term, 12 Month, and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Rubicon_Research_Share_Price_Target\"><\/span><strong>Short Term Rubicon Research Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Near-term support for Rubicon Research is anchored close to the 52 week low of Rs 570.75. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating from CMP Rs 1,408.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Rubicon_Research_Share_Price_Target_2026\"><\/span><strong>12-Month Rubicon Research Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Rubicon Research share price target 2026<\/strong> is Rs 1,700, implying approximately 20 percent upside from CMP Rs 1,408. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Rubicon_Research_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Rubicon Research Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>long term Rubicon Research share price target<\/strong> for FY27 to FY28 is Rs 2,050 in the bull case, requiring full earnings delivery, re-rating among peers in CDMO like Suven Pharma and Piramal Pharma, and sustained institutional buying over a 2 to 3 year horizon.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_Scenarios_for_Rubicon_Research_in_2026\"><\/span><strong>Bull Case and Bear Case Scenarios for Rubicon Research in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Rubicon_Research_Share_Price_Target_Rs_2050\"><\/span><strong>Bull Case Rubicon Research Share Price Target: Rs 2,050<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bull case Rubicon Research share price target<\/strong> of Rs 2,050 materialises when FY27 earnings beat analyst estimates, Pharmaceutical CDMO and Formulations tailwinds accelerate, and FII flows return strongly to Indian equities, representing approximately 45 percent potential upside from CMP Rs 1,408.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Rubicon_Research_Share_Price_Target_Rs_1150\"><\/span><strong>Bear Case Rubicon Research Share Price Target: Rs 1,150<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bear case Rubicon Research share price target<\/strong> of Rs 1,150 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of support near the 52 week low of Rs 570.75.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 2,050<\/td>\n<td>FY27 beat, sector re-rating, FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Analyst Target)<\/td>\n<td>Rs 1,700<\/td>\n<td>In-line FY27 delivery, partial FII recovery<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 1,150<\/td>\n<td>FY27 miss, guidance cut, FII outflows persist<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_That_Could_Derail_the_Rubicon_Research_2026_Price_Objective\"><\/span><strong>Key Risks That Could Derail the Rubicon Research 2026 Price Objective<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Global_Macro_and_US_Tariff_Headwinds\"><\/span><strong>Global Macro and US Tariff Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the <strong>Rubicon Research share price target<\/strong> of Rs 1,700, with FII outflows being the direct transmission mechanism to Indian equity valuations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Miss_and_Guidance_Risk\"><\/span><strong>FY27 Earnings Miss and Guidance Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>An FY27 earnings miss or downward guidance revision would compress valuation multiples and is the most direct company-specific risk to the Rs 1,700 analyst price objective. Investors must monitor quarterly results and management commentary closely.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Intensity_Among_Pharmaceutical_CDMO_and_Formulations_Peers\"><\/span><strong>Competitive Intensity Among Pharmaceutical CDMO and Formulations Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition from peers in CDMO like Suven Pharma and Piramal Pharma could compress Rubicon Research&#8217;s market share and pricing power, a structural risk that must be weighed when assessing the defensibility of the earnings trajectory underpinning the Rs 1,700 analyst target for 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Liquidity_Risk_and_FII_Selling_Pressure\"><\/span><strong>Liquidity Risk and FII Selling Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should maintain position sizing discipline and stop losses to protect capital.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Rubicon_Research\"><\/span><strong>How to Invest in Rubicon Research<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<p>Before considering any investment based on the <strong>Rubicon Research share price target<\/strong> of Rs 1,700, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on Pharmaceutical CDMO and Formulations sector demand.<\/p>\n<p>Open a Demat account with a SEBI registered stockbroker to trade Rubicon Research (NSE: RUBICON) with full regulatory protection. Study the competitive landscape among peers in CDMO like Suven Pharma and Piramal Pharma before executing any position.<\/p>\n<p>Plan your entry using the 52 week low of Rs 570.75 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 1,700 price objective. Always set a stop loss below the 52 week low.<\/p>\n<p>Restrict any single stock to 3 to 5 percent of your total equity portfolio. Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Rubicon Research&#8217;s live share price and receive daily stock recommendations.<\/em><\/p>\n<div style=\"background: #C0392B; padding: 20px 24px; border-radius: 4px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 15px; font-weight: bold; margin: 0; line-height: 1.7;\"><strong>Disclaimer Note:<\/strong> The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Rubicon_Research_Share_Price_Target_2026\"><\/span><strong>FAQs on Rubicon Research Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Rubicon_Research_share_price_target_for_2026\"><\/span><strong>What is the Rubicon Research share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Rubicon Research share price target 2026 is Rs 1,700, implying approximately 20 percent upside from CMP Rs 1,408. Bull case is Rs 2,050, bear case is Rs 1,150.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Rubicon_Research_share_price_target_for_2025\"><\/span><strong>What was the Rubicon Research share price target for 2025?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 2025 price objective for Rubicon Research was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 1,700, reflecting FY27 growth potential from CMP Rs 1,408.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Rubicon_Research_a_good_investment_at_Rs_1408\"><\/span><strong>Is Rubicon Research a good investment at Rs 1,408?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At Rs 1,408, Rubicon Research offers potential upside toward Rs 1,700 if FY27 earnings recover. Whether this represents a good entry depends on individual risk tolerance. Consult a SEBI registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Rubicon_Research_share_price_target_2026\"><\/span><strong>What are the key risks to the Rubicon Research share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Rubicon Research share price target of Rs 1,700 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Pharmaceutical CDMO and Formulations. Monitoring quarterly results is essential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Rubicon_Research\"><\/span><strong>What is the 52 week high and low of Rubicon Research?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Rubicon Research is Rs 1,469 and the 52 week low is Rs 570.75. At CMP Rs 1,408, the stock offers potential upside toward the Rs 1,700 price objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_growth_catalysts_for_Rubicon_Research_in_2026\"><\/span><strong>What are the main growth catalysts for Rubicon Research in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key catalysts include FY27 PAT recovery, Pharmaceutical CDMO and Formulations tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Rubicon_Research_compare_to_its_peers\"><\/span><strong>How does Rubicon Research compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Rubicon Research operates in Pharmaceutical CDMO and Formulations alongside peers in CDMO like Suven Pharma and Piramal Pharma. At CMP Rs 1,408 with MCap Rs 23,037 crore, it is a potential re-rating candidate toward the Rubicon Research share price target of Rs 1,700 on FY27 delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Rubicon_Research_share_price_target_for_2027\"><\/span><strong>What is the Rubicon Research share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Rubicon Research share price target for FY27 to FY28 is Rs 2,050 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Rubicon Research share price target 2026 is Rs 1,700, ~20% upside from CMP Rs 1,408. Bull Rs 2,050, bear Rs 1,150. 2026.<\/p>\n","protected":false},"author":35,"featured_media":131801,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3972],"class_list":["post-131482","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-target"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782388511:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Rubicon Research Share Price Target 2026: Rs 1,700 Analyst Forecast"],"rank_math_description":["The Rubicon Research share price target 2026 is Rs 1,700, ~20% upside from CMP Rs 1,408. Bull Rs 2,050, bear Rs 1,150. 2026."],"rank_math_focus_keyword":["Rubicon Research Share Price Target"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["131801"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["21390"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Rubicon-Research-Share-Price-Target.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/131482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=131482"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/131482\/revisions"}],"predecessor-version":[{"id":131802,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/131482\/revisions\/131802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/131801"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=131482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=131482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=131482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}